Acitretin [55079-83-9]
A0933
Product group Chemicals
Overview
- SupplierLKT Laboratories
- Product NameAcitretin [55079-83-9]
- Delivery Days Customer7
- CertificationResearch Use Only
- Scientific DescriptionRetinoid; RARalfa/bèta/gamma agonist.; Neotigason, Soriatane
- UNSPSC12352200
References
- Niu X, Cao W, Ma H, et al. Acitretin exerted a greater influence on T-helper (Th)1 and Th17 than on Th2 cells in treatment of psoriasis vulgaris. J Dermatol. 2012 Nov;39(11):916-21. PMID: 22913391. Saurat JH. Retinoids and psoriasis: novel issues in retinoid pharmacology and implications for psoriasis treatment. J Am Acad Dermatol. 1999 Sep;41(3 Pt 2):S2-6. PMID: 10459139. Raynaud F, Gerbaud P, Bouloc A, et al. Rapid effect of treatment of psoriatic erythrocytes with the synthetic retinoid acitretin to increase 8-azido cyclic AMP binding to the RI regulatory subunit. J Invest Dermatol. 1993 Jan;100(1):77-81. PMID: 8380830.